Back to top of page

Cancer Adoptive Cellular Therapy Network (Can-ACT) for Pediatric Cancers (UG3/UH3 Clinical Trial Required)

Required information for the Can-ACT grant application:

1. Research Project Description: Provide a detailed description of the proposed research project, including the aim, objectives, and significance of the study.

2. Research Plan: Outline the specific research plan, including study design, methodology, and experimental procedures.

3. Collaborative Approach: Describe the collaborative approach to preclinical testing and translational studies, highlighting how the multi-investigator team will work together to bring new cell therapy products to the clinic.

4. Expertise and Qualifications: Provide information on the expertise and qualifications of the multi-investigator team members, including their relevant experience in cellular therapy and pediatric oncology.

5. Budget and Justification: Present a detailed budget for the proposed research project, including funding requested for personnel, supplies, equipment, and other expenses. Justify the requested budget based on the needs of the study.

6. Timeline and Milestones: Outline a timeline for the proposed research project, including key milestones and expected completion dates for each phase of the study.

7. Evaluation and Outcome Measures: Describe the evaluation and outcome measures that will be used to assess the success and impact of the proposed research project.

8. Institutional Support: Provide information on the support and resources available at the applicant institution to carry out the proposed research project.

9. Ethical Considerations: Discuss the ethical considerations related to the proposed research project, including informed consent, protection of human subjects, and compliance with relevant regulations and guidelines.

10. Dissemination Plan: Outline a plan for disseminating the results of the research project, including publication in scientific journals, presentations at conferences, and sharing of data and resources.

11. Project Team: Provide a list of the project team members, their roles, and their institutional affiliations.

12. Data Management and Analysis: Describe the proposed data management and analysis plan, including how the collected data will be stored, analyzed, and reported.

13. Regulatory Approvals: Indicate any regulatory approvals that will be required for the proposed research project, such as Institutional Review Board (IRB) approval or Investigational New Drug (IND) application.

14. Potential Risks and Mitigation Strategies: Identify potential risks and challenges associated with the proposed research project and provide strategies for mitigating these risks.

15. Letter of Support: Include letters of support from collaborating institutions and individuals, highlighting their commitment to the project and their role in its success.

16. References: Provide a list of references cited in the

Apply Now
Dollar sign symbol

Funding Amount

Clipboard symbol with a small checkmark bottom right

Eligible Applicants

Checkmark

Eligible Activities

Clock symbol

Deadline to Apply

Apply for Funding

88%

Approval rating across all Canadian funding programs

93%

Average time savings to our clients, compared to
businesses that apply for funding in-house
Woman on high chair reading a book in a small room with windows